Skip to main content
DELTEX MEDICAL GROUP PLC logo

DELTEX MEDICAL GROUP PLC — Investor Relations & Filings

Ticker · DEMG ISIN · GB0059337583 LEI · 213800XN34P6LI8J6M39 IL Manufacturing
Open in API
Filings indexed 332 across all filing types
Latest filing 2024-07-04 Earnings Release
Country GB United Kingdom
Listing IL DEMG

About DELTEX MEDICAL GROUP PLC

https://www.deltexmedical.com/

Deltex Medical Group PLC is a developer and manufacturer of advanced haemodynamic monitoring systems for use in surgery and critical care. The company's core technology is Oesophageal Doppler Monitoring (ODM), a minimally-invasive platform that provides clinicians with real-time data on cardiac function and fluid status. This technology is designed to guide fluid and drug administration, helping to improve patient outcomes and reduce postoperative complications. The company's product portfolio is centered on its ODM technology, featuring the next-generation TrueVue™ system. The TrueVue™ platform offers enhanced signal acquisition, an intuitive user interface, and portability with an integrated battery, allowing for continuous patient monitoring across various clinical environments.

Recent filings

Filing Released Lang Actions
Half-year Trading Update
Earnings Release Classification · 99% confidence The document is identified by the RNS Number header and the presence of 'RNS Number : 0636V' and the closing statement referencing 'RNS, the news service of the London Stock Exchange'. The content is a 'Half Year Trading Update' providing unaudited revenues, EBITDA status, and cash position for the six months ended 30 June 2024. This structure—a brief update on financial performance for an interim period—aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it contains trading highlights, it is a comprehensive update for the half-year, not just the initial 'Earnings Release' (ER). It is not a short announcement about a report, but the report update itself. H1 2024
2024-07-04 English
New share plans and grant of share options
Remuneration Information Classification · 99% confidence The document is an official announcement released via RNS (the news service of the London Stock Exchange) on June 12, 2024. The content details the adoption of new share incentive plans and the grant of share options to directors and employees. Crucially, the final section is titled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them' and details the grant of options to directors (Andrew Mears and Natalie Wettler). This structure strongly indicates a mandatory disclosure related to insider transactions or director dealings, which aligns with the 'Director's Dealing' definition (DIRS). While it involves share options (which could relate to CAP or SHA), the primary regulatory focus here is the disclosure of transactions by PDMRs (Persons Discharging Managerial Responsibilities). Since DIRS specifically covers 'Report of personal share transactions by company directors and executives (insider trades)', this is the most precise classification for this type of regulatory filing concerning executive compensation/transactions.
2024-06-12 English
Group of companies' accounts made up to 2023-12-31
Regulatory Filings
2024-06-05 English
Award to NHS Supply Chain Framework Agreement
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' (9383Q) and is dated 04 June 2024. It announces a significant business event: Deltex Medical Group plc being awarded a national framework tender by NHS Supply Chain for its new TrueVue System. This type of announcement, detailing a contract award or major operational update released via the Regulatory News Service (RNS) system, is characteristic of a general regulatory announcement that doesn't fit the specific financial report categories (like 10-K, IR, ER). Since it is a formal announcement disseminated through the RNS system and concerns a business development rather than a specific financial filing or management change, the most appropriate classification is Regulatory Filings (RNS), which serves as the general regulatory announcement category.
2024-06-04 English
Result of Annual General Meeting
AGM Information Classification · 99% confidence The document is an official announcement released via RNS (RNS Number: 6474N) on May 8, 2024. The title explicitly states 'Result of Annual General Meeting' and the body confirms that 'at the Group's annual general meeting held earlier today, all the resolutions were duly passed.' This content directly relates to the outcome of the Annual General Meeting (AGM). While it reports the result, it is not the proxy statement (PSI) or the voting results declaration (DVA), but rather the official confirmation of the meeting's conclusion, which aligns best with AGM-R (AGM Information/Results). Since it is a short announcement confirming the outcome of the meeting, it fits the AGM-R category better than a general Regulatory Filing (RNS).
2024-05-08 English
Chairman’s Statement to the Annual General Meeting
AGM Information Classification · 99% confidence The document explicitly states it is the "Chairman's Statement to the Annual General Meeting" and references the meeting date ("At today's Annual General Meeting"). This content, which summarizes progress and outlook presented at the AGM, aligns perfectly with the definition of AGM Information (AGM-R). Although it is an RNS filing (indicated by the RNS Number and footer), the core content is the AGM statement itself, making AGM-R the most specific classification.
2024-05-08 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.